iBio Inc.

NASDAQ: IBIO
Share price (5/30/25): $0.77
Market cap (5/30/25): $12.7 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/25 Q3

ended 12/31/24 Q2

ended 09/30/24 Q1

ended 06/30/24 FY 2024 – amended

ended 06/30/24 FY 2024

Prospectuses and Registrations Filter

Exempt offering of securities

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Removal from listing

Ownership Filter

Opaleye Management Inc.

ADAR1 Capital Management, LLC

News Filter

Reports Fiscal Third Quarter 2025 Financial Results

Expands Cardiometabolic and Obesity Pipeline Through Licensing of First-In-Class Antibody Targeting Activin E From AstralBio

Investor Presentation

Announces IBIO-600 Non-Human Primate Data Showing Extended Half-Life and Muscle Growth, and Interim in Vivo Results for First-In-Class Activin E Antibody, Advancing Cardiometabolic and Obesity Pipeline

To Begin Trading on the Nasdaq Stock Exchange

Proxies Filter

Definitive proxy

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission